B+
Bull case
20%
Probability
Target price
$0.15
-96.5% vs current
SSII
SS Innovations InternationalFNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-03
AI scenario view
RankAlpha Sentiment AIMost likely
B
Base case
50%
Probability
Target price
$0.09
-97.9% vs current
B-
Bear case
30%
Probability
Target price
$0.04
-99.1% vs current
AI sentiment snapshot
Latest data as of 2025-12-13
Recent news sentiment (30D)
-26.5
Negative
Company
-
Unavailable
Macro
-26.5
Negative
Pulse
-
Unavailable
Sentiment proxy
0.0
Score
AI commentary
Public and regulatory filings emphasize financing needs and lack of revenues, producing a cautious market tone [#10Q-2023-11-13]. Market price is at penny-stock levels with limited liquidity; the price anchor used here is a yfinance fallback close reflecting that low market valuation [#yfinance-2025-11-16T20:00:00Z]. Overall investor sentiment appears risk-averse, with upside dependent on de-risking events.
RankAlpha Sentiment AI - 2025-12-13
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
-eventRegulatory or commercial milestoneHigh impact
Positive regulatory clearance, pilot commercial agreement, or partnership would be disproportionally impactful given the company's zero-revenue base and could drive short-term rallies [#10Q-2023-11-13].
-catalystNo revenues; going-concern / dilution riskHigh impact
Company disclosed no revenues and ongoing need for financing in the most recent 10-Q, creating high dilution and downside risk to equity holders [#10Q-2023-11-13].
-catalystSuccessful financing / capital raiseHigh impact
A completed financing that materially extends the runway or funds commercialization could materially de-risk the equity and lead to a re-rating from current penny-stock levels [#10Q-2023-11-13].
Recommendation
N/A
No formal recommendation provided.
As of 2025-12-13 • Updated nightlySource: Internal modelMethodology